| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.19 | 0.2 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.2 | 0.3 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |